An organoid-based screen for epigenetic inhibitors that stimulate antigen presentation and potentiate T-cell-mediated cytotoxicity

Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625 · see citing works

STAR: ultrafast universal RNA-seq aligner

Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709 · see citing works

<tt>edgeR</tt> : a Bioconductor package for differential expression analysis of digital gene expression data

Robinson, M. D., McCarthy, D. J., & Smyth, G. K. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp616 · Cited by 41,364 · see citing works

featureCounts: an efficient general purpose program for assigning sequence reads to genomic features

Liao, Y., Smyth, G. K., & Shi, W. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt656 · Cited by 27,219 · see citing works

Complex heatmaps reveal patterns and correlations in multidimensional genomic data

Gu, Z., Eils, R., & Schlesner, M. (2016) · Bioinformatics · doi:10.1093/bioinformatics/btw313 · Cited by 10,122 · see citing works

DAVID: Database for Annotation, Visualization, and Integrated Discovery

Dennis, G., Sherman, B. T., Hosack, D. A., Yang, J., Gao, W., Lane, H. C., & Lempicki, R. A. (2003) · Genome Biology · doi:10.1186/gb-2003-4-5-p3 · Cited by 9,327 · see citing works

Microenvironmental regulation of tumor progression and metastasis

Quail, D. F., & Joyce, J. A. (2013) · Nature Medicine · doi:10.1038/nm.3394 · Cited by 7,994 · see citing works

Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche

Sato, T., Vries, R. G., Snippert, H. J., van de Wetering, M., Barker, N., Stange, D. E., van Es, J. H., Abo, A., Kujala, P., Peters, P. J., et al. (2009) · Nature · doi:10.1038/nature07935 · Cited by 7,204 · see citing works

Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation

McCarthy, D. J., Chen, Y., & Smyth, G. K. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks042 · Cited by 5,195 · see citing works

Atezolizumab and nab-paclitaxel in advanced triple-negative breast cancer

Schmid, P., Adams, S., Rugo, H. S., Schneeweiss, A., Barrios, C. H., Iwata, H., Diéras, V., Hegg, R., Im, S.-A., Shaw Wright, G., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1809615 · Cited by 4,350 · see citing works

Microenvironmental regulation of metastasis

Joyce, J. A., & Pollard, J. W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2618 · Cited by 3,684 · see citing works

Modeling Development and Disease with Organoids

Clevers, H. (2016) · Cell · doi:10.1016/j.cell.2016.05.082 · Cited by 3,196 · see citing works

Influence of tumour micro-environment heterogeneity on therapeutic response

Junttila, M. R., & de Sauvage, F. J. (2013) · Nature · doi:10.1038/nature12626 · Cited by 2,694 · see citing works

DAVID: Database for Annotation, Visualization, and Integrated Discovery

Dennis, G., Sherman, B. T., Hosack, D. A., Yang, J., Gao, W., Lane, H. C., & Lempicki, R. A. (2003) · Genome biology · doi:10.1186/gb-2003-4-9-r60 · Cited by 2,383 · see citing works

A living biobank of breast cancer organoids captures disease heterogeneity

Sachs, N., de Ligt, J., Kopper, O., Gogola, E., Bounova, G., Weeber, F., Balgobind, A. V., Wind, K., Gracanin, A., Begthel, H., et al. (2018) · Cell · doi:10.1016/j.cell.2017.11.010 · Cited by 1,973 · see citing works

Spheroid-based drug screen: Considerations and practical approach

Friedrich, J., Seidel, C., Ebner, R., & Kunz-Schughart, L. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.226 · Cited by 1,742 · see citing works

Pathways of Antigen Processing

Blum, J. S., Wearsch, P. A., & Cresswell, P. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095910 · Cited by 1,561 · see citing works

Organoid modeling of the tumor immune microenvironment

Neal, J. T., Li, X., Zhu, J., Giangarra, V., Grzeskowiak, C. L., Ju, J., Liu, I. H., Chiou, S.-H., Salahudeen, A. A., Smith, A. R., et al. (2018) · Cell · doi:10.1016/j.cell.2018.11.021 · Cited by 1,556 · see citing works

Organoids as an in vitro model of human development and disease

Fatehullah, A., Tan, S. H., & Barker, N. (2016) · Nature Cell Biology · doi:10.1038/ncb3312 · Cited by 1,508 · see citing works

Human primary liver cancer–derived organoid cultures for disease modeling and drug screening

Broutier, L., Mastrogiovanni, G., Verstegen, M. M., Francies, H. E., Gavarró, L. M., Bradshaw, C. R., Allen, G. E., Arnes-Benito, R., Sidorova, O., Gaspersz, M. P., et al. (2017) · Nature Medicine · doi:10.1038/nm.4438 · Cited by 1,471 · see citing works

IFNγ: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy

Ivashkiv, L. B. (2018) · Nature reviews. Immunology · doi:10.1038/s41577-018-0029-z · Cited by 1,374 · see citing works

Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor Organoids

Dijkstra, K. K., Cattaneo, C. M., Weeber, F., Chalabi, M., van de Haar, J., Fanchi, L. F., Slagter, M., van der Velden, D. L., Kaing, S., Kelderman, S., et al. (2018) · Cell · doi:10.1016/j.cell.2018.07.009 · Cited by 1,135 · see citing works

Potentiating the antitumour response of CD8+ T cells by modulating cholesterol metabolism

Yang, W., Bai, Y., Xiong, Y., Zhang, J., Chen, S., Zheng, X., Meng, X., Li, L., Wang, J., Xu, C., et al. (2016) · Nature · doi:10.1038/nature17412 · Cited by 1,010 · see citing works

The role of TNF superfamily members in T-cell function and diseases

Croft, M. (2009) · Nature reviews. Immunology · doi:10.1038/nri2526 · Cited by 924 · see citing works

Tumor Evolution and Drug Response in Patient-Derived Organoid Models of Bladder Cancer

Lee, S. H., Hu, W., Matulay, J. T., Silva, M. V., Owczarek, T. B., Kim, K., Chua, C. W., Barlow, L. J., Kandoth, C., Williams, A. B., et al. (2018) · Cell · doi:10.1016/j.cell.2018.03.017 · Cited by 873 · see citing works

NY-ESO-1–specific TCR–engineered T cells mediate sustained antigen-specific antitumor effects in myeloma

Rapoport, A. P., Stadtmauer, E. A., Binder-Scholl, G. K., Goloubeva, O. G., Vogl, D. T., Lacey, S. F., Badros, A. Z., Garfall, A. L., Weiss, B. M., Finklestein, J. M., et al. (2015) · Nature Medicine · doi:10.1038/nm.3910 · Cited by 857 · see citing works

The Basis of Oncoimmunology

Palucka, A. K., & Coussens, L. M. (2016) · Cell · doi:10.1016/j.cell.2016.01.049 · Cited by 843 · see citing works

Patient-derived lung cancer organoids as in vitro cancer models for therapeutic screening

Kim, M., Mun, H., Sung, C. O., Cho, E. J., Jeon, H.-J., Chun, S.-M., Jung, D. J., Shin, T. H., Jeong, G. S., Kim, D. K., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11867-6 · Cited by 812 · see citing works

Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer

Zacharakis, N., Chinnasamy, H., Black, M. A., Xu, H., Lu, Y., Zheng, Z., Pasetto, A., Langhan, M. M., Shelton, T. E., Prickett, T. D., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0040-8 · Cited by 770 · see citing works

Organoid culture systems for prostate epithelial and cancer tissue

Drost, J., Karthaus, W. R., Gao, D., Driehuis, E., Sawyers, C. L., Chen, Y., & Clevers, H. C. (2016) · Nature Protocols · doi:10.1038/nprot.2016.006 · Cited by 694 · see citing works

LSD1 Ablation Stimulates Anti-tumor Immunity and Enables Checkpoint Blockade

Sheng, W., LaFleur, M. W., Nguyen, T. H., Chen, S., Chakravarthy, A., Conway, J. R., Li, Y., Chen, H., Yang, H., Hsu, P.-H., et al. (2018) · Cell · doi:10.1016/j.cell.2018.05.052 · Cited by 693 · see citing works

MHC Class I Antigen Processing and Presenting Machinery: Organization, Function, and Defects in Tumor Cells

Leone, P., Shin, E.-C., Perosa, F., Vacca, A., Dammacco, F., & Racanelli, V. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt184 · Cited by 553 · see citing works

Myeloid-Derived Suppressor Cells: Immune-Suppressive Cells That Impair Antitumor Immunity and Are Sculpted by Their Environment

Ostrand-Rosenberg, S., & Fenselau, C. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701019 · Cited by 509 · see citing works

Tumor organoid–T-cell coculture systems

Cattaneo, C. M., Dijkstra, K. K., Fanchi, L. F., Kelderman, S., Kaing, S., van Rooij, N., van den Brink, S., Schumacher, T. N., & Voest, E. E. (2020) · Nature Protocols · doi:10.1038/s41596-019-0232-9 · Cited by 410 · see citing works

Colonic organoids derived from human induced pluripotent stem cells for modeling colorectal cancer and drug testing

Crespo, M., Vilar, E., Tsai, S.-Y., Chang, K., Amin, S., Srinivasan, T., Zhang, T., Pipalia, N. H., Chen, H. J., Witherspoon, M., et al. (2017) · Nature Medicine · doi:10.1038/nm.4355 · Cited by 399 · see citing works

Mannose 6-Phosphate/Insulin-like Growth Factor II Receptor Is a Death Receptor for Granzyme B during Cytotoxic T Cell–Induced Apoptosis

Motyka, B., Korbutt, G. S., Pinkoski, M. J., Heibein, J. A., Caputo, A., Hobman, M., Barry, M., Shostak, I., Sawchuk, T., Holmes, C. F. B., et al. (2000) · Cell · doi:10.1016/s0092-8674(00)00140-9 · Cited by 398 · see citing works

CD8+ T cell efficacy in vaccination and disease

Appay, V., Douek, D. C., & Price, D. A. (2008) · Nature Medicine · doi:10.1038/nm.f.1774 · Cited by 393 · see citing works

A phase II study of the histone deacetylase inhibitor vorinostat combined with tamoxifen for the treatment of patients with hormone therapy-resistant breast cancer

Munster, P. N., Thurn, K. T., Thomas, S., Raha, P., Lacevic, M., Miller, A., Melisko, M., Ismail-Khan, R., Rugo, H., Moasser, M., et al. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.156 · Cited by 391 · see citing works

Landscape of immunogenic tumor antigens in successful immunotherapy of virally-induced epithelial cancer

Stevanović, S., Pasetto, A., Helman, S. R., Gartner, J. J., Prickett, T. D., Howie, B., Robins, H., Robbins, P., Klebanoff, C., Rosenberg, S., et al. (2017) · Science · doi:10.1126/science.aak9510 · Cited by 364 · see citing works

Organoid technology and applications in cancer research

Xu, H., Lyu, X., Yi, M., Zhao, W., Song, Y., & Wu, K. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0662-9 · Cited by 350 · see citing works

Immuno-subtyping of breast cancer reveals distinct myeloid cell profiles and immunotherapy resistance mechanisms

Kim, I. S., Gao, Y., Welte, T., Wang, H., Liu, J., Janghorban, M., Sheng, K., Niu, Y., Goldstein, A., Zhao, N., et al. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0373-7 · Cited by 334 · see citing works

Characterization of the ovalbumin‐specific TCR transgenic line OT‐I: MHC elements for positive and negative selection

Clarke, S. R. M., Barnden, M., Kurts, C., Carbone, F., Miller, J. F. A. P., & Heath, W. R. (2000) · Immunology and Cell Biology · doi:10.1046/j.1440-1711.2000.00889.x · Cited by 296 · see citing works

A simple high-throughput approach identifies actionable drug sensitivities in patient-derived tumor organoids

Phan, N., Hong, J. J., Tofig, B., Mapua, M., Elashoff, D., Moatamed, N. A., Huang, J., Memarzadeh, S., Damoiseaux, R., & Soragni, A. (2019) · Communications Biology · doi:10.1038/s42003-019-0305-x · Cited by 269 · see citing works

Inhibition of histone deacetylases in cancer therapy: lessons from leukaemia

Ceccacci, E., & Minucci, S. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.36 · Cited by 256 · see citing works

Adoptive T-Cell Therapy Using Autologous Tumor-Infiltrating Lymphocytes for Metastatic Melanoma

Wu, R. C. H., Forget, M., Chacon, J. A., Bernatchez, C., Haymaker, C., Chen, J. Q., Hwu, P., & Radvanyi, L. G. (2012) · The Cancer Journal · doi:10.1097/ppo.0b013e31824d4465 · Cited by 248 · see citing works

Reprogramming of the Tumor in the Hypoxic Niche: The Emerging Concept and Associated Therapeutic Strategies

Qiu, G., Jin, M., Dai, J., Sun, W., Feng, J., & Jin, W. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.05.002 · Cited by 245 · see citing works

TP53 loss creates therapeutic vulnerability in colorectal cancer

Liu, Y., Zhang, X., Han, C., Wan, G., Huang, X., Ivan, C., Jiang, D., Rodriguez‐Aguayo, C., Lopez‐Berestein, G., Rao, P. H., et al. (2015) · Nature · doi:10.1038/nature14418 · Cited by 240 · see citing works

The Contribution of Epigenetics to Cancer Immunotherapy

Villanueva, L., Álvarez‐Errico, D., & Esteller, M. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.06.002 · Cited by 234 · see citing works

Application of Cancer Organoid Model for Drug Screening and Personalized Therapy

Kondo, J., & Inoue, M. (2019) · Cells · doi:10.3390/cells8050470 · Cited by 224 · see citing works

CUDC-101, a Multitargeted Inhibitor of Histone Deacetylase, Epidermal Growth Factor Receptor, and Human Epidermal Growth Factor Receptor 2, Exerts Potent Anticancer Activity

Lai, C.-J., Bao, R., Tao, X., Wang, J., Atoyan, R., Qu, H., Wang, D.-G., Yin, L., Samson, M., Forrester, J. S., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3360 · Cited by 214 · see citing works

If we build it they will come: targeting the immune response to breast cancer

Gatti-Mays, M. E., Balko, J. M., Gameiro, S. R., Bear, H. D., Prabhakaran, S., Fukui, J. A., Disis, M. L., Nanda, R., Gulley, J. L., Kalinsky, K. M., et al. (2019) · npj Breast Cancer · doi:10.1038/s41523-019-0133-7 · Cited by 207 · see citing works

HDAC inhibition potentiates immunotherapy in triple negative breast cancer

Terranova-Barberio, M., Thomas, S., Ali, N., Pawlowska, N., Park, J., Krings, G., Rosenblum, M. D., Budillon, A., & Munster, P. N. (2017) · Oncotarget · doi:10.18632/oncotarget.23169 · Cited by 182 · see citing works

Memory T cells targeting oncogenic mutations detected in peripheral blood of epithelial cancer patients

Cafri, G., Yossef, R., Pasetto, A., Deniger, D. C., Lu, Y., Parkhurst, M. R., Gartner, J. J., Jia, L., Ray, S., Ngo, L. T., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08304-z · Cited by 165 · see citing works

Organoids as a new model for improving regenerative medicine and cancer personalized therapy in renal diseases

Grassi, L., Alfonsi, R., Francescangeli, F., Signore, M., Angelis, M. L. D., Addario, A., Costantini, M., Flex, E., Ciolfi, A., Pizzi, S., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1453-0 · Cited by 160 · see citing works

Epigenetic and Transcriptomic Profiling of Mammary Gland Development and Tumor Models Disclose Regulators of Cell State Plasticity

Dravis, C., Chung, C., Lytle, N. K., Herrera-Valdez, J., Luna, G., Trejo, C. L., Reya, T., & Wahl, G. M. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.08.001 · Cited by 142 · see citing works

New dimensions in tumor immunology: what does 3D culture reveal?

Feder-Mengus, C., Ghosh, S., Reschner, A., Martin, I., & Spagnoli, G. C. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2008.06.001 · Cited by 139 · see citing works

PTP1B controls non-mitochondrial oxygen consumption by regulating RNF213 to promote tumour survival during hypoxia

Banh, R. S., Iorio, C., Marcotte, R., Xu, Y., Cojocari, D., Rahman, A. M. A., Pawling, J., Zhang, W., Sinha, A., Rose, C. M., et al. (2016) · Nature Cell Biology · doi:10.1038/ncb3376 · Cited by 136 · see citing works

Immunoepigenetics Combination Therapies: An Overview of the Role of HDACs in Cancer Immunotherapy

Banik, D., Moufarrij, S., & Villagra, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092241 · Cited by 134 · see citing works

Checkpoint blockade in the treatment of breast cancer: current status and future directions

Wein, L., Luen, S. J., Savas, P. S., Salgado, R., & Loi, S. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0126-6 · Cited by 115 · see citing works

Phosphatidylserine-targeting antibodies augment the anti-tumorigenic activity of anti-PD-1 therapy by enhancing immune activation and downregulating pro-oncogenic factors induced by T-cell checkpoint inhibition in murine triple-negative breast cancers

Gray, M. J., Gong, J., Hatch, M. M. S., Nguyen, V., Hughes, C. C. W., Hutchins, J. T., & Freimark, B. D. (2016) · Breast Cancer Research · doi:10.1186/s13058-016-0708-2 · Cited by 77 · see citing works

Myeloid-Derived Suppressor Cells Specifically Suppress IFN-γ Production and Antitumor Cytotoxic Activity of Vδ2 T Cells

Sacchi, A., Tumino, N., Sabatini, A., Cimini, E., Casetti, R., Bordoni, V., Grassi, G., & Agrati, C. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01271 · Cited by 63 · see citing works

Inhibition of the function of class IIa HDACs by blocking their interaction with MEF2

Jayathilaka, N., Han, A., Gaffney, K. J., Dey, R., Jarusiewicz, J., Noridomi, K., Philips, M. A., Lei, X., He, J., Ye, J., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks189 · Cited by 54 · see citing works

Immune-checkpoint inhibition for metastatic triple-negative breast cancer: safety first?

D’Abreo, N., & Adams, S. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0216-2 · Cited by 53 · see citing works

ST2 as checkpoint target for colorectal cancer immunotherapy

der Jeught, K. V., Sun, Y., Fang, Y., Zhou, Z., Jiang, H., Yu, T., Yang, J., Kamocka, M. M., So, K. M., Li, Y., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.136073 · Cited by 48 · see citing works

Co-inhibition of mTORC1, HDAC and ESR1α retards the growth of triple-negative breast cancer and suppresses cancer stem cells

Sulaiman, A., McGarry, S., Lam, K. M., El‐Sahli, S., Chambers, J., Kaczmarek, S., Li, L., Addison, C., Dimitroulakos, J., Arnaout, A., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0811-7 · Cited by 46 · see citing works

HDAC inhibitors tested in phase III trial

Romero, D. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0224-2 · Cited by 43 · see citing works

Re-oxygenation causes hypoxic tumor regression through restoration of p53 wild-type conformation and post-translational modifications

Gogna, R., Madan, E., Kuppusamy, P., & Pati, U. (2012) · Cell Death and Disease · doi:10.1038/cddis.2012.15 · Cited by 40 · see citing works

Deoxyribonuclease II as a probe for chromatin structure

Hörz, W., Miller, F., Klobeck, G., & Zachau, H. G. (1980) · Journal of Molecular Biology · doi:10.1016/0022-2836(80)90094-7 · Cited by 20 · see citing works

Dose‐ and Dosage Form‐Dependent Pharmacokinetics of Phenacetin and its Metabolite in Man

Chiou, W. L. (1974) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1974.tb02323.x · Cited by 12 · see citing works

Organoids predict clinical responses

Bradley, C. A. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2018.25 · Cited by 7 · see citing works

Studying tumour-specific T cell responses in 3D

Minton, K. (2018) · Nature reviews. Immunology · doi:10.1038/s41577-018-0058-7 · Cited by 4 · see citing works

A model for tumor–immune interaction

de Souza, N. (2018) · Nature Methods · doi:10.1038/s41592-018-0165-1 · Cited by 4 · see citing works

[A C T H (author's transl)].

Akira, K. A. W. A. (1977) · PubMed · Cited by 2 · see citing works

Abstract P4-04-03: Targeting of phosphatidylserine by monoclonal antibodies augments the activity of immune checkpoint inhibitor PD-1/PD-L1 therapy in murine breast tumors

Gray, M. J., Gong, J., Nguyen, V., Hutchins, J., & Freimark, B. D. (2016) · Cancer Research · doi:10.1158/1538-7445.sabcs15-p4-04-03 · Cited by 1 · see citing works

Drug repurposing for cancer therapy

Xia, Y., Sun, M., Huang, H., & Jin, W.-L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01808-1 · Cited by 443 · see citing works

Tumor organoids: applications in cancer modeling and potentials in precision medicine

Xu, H., Jiao, D., Liu, A., & Wu, K. (2022) · Journal of Hematology &amp; Oncology · doi:10.1186/s13045-022-01278-4 · Cited by 286 · see citing works

OrganoID: A versatile deep learning platform for tracking and analysis of single-organoid dynamics

Matthews, J. M., Schuster, B., Kashaf, S. S., Liu, P., Ben-Yishay, R., Ishay-Ronen, D., Izumchenko, E., Shen, L., Weber, C. R., Bielski, M. C., et al. (2022) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1010584 · Cited by 179 · see citing works

3D cell cultures toward quantitative high-throughput drug screening

Wang, Y., & Jeon, H. (2022) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2022.03.014 · Cited by 143 · see citing works

Strategies for 3D bioprinting of spheroids: A comprehensive review

Banerjee, D., Singh, Y. P., Datta, P., Özbolat, V., O'Donnell, A., Yeo, M., & Ozbolat, I. T. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121881 · Cited by 117 · see citing works

Decorating Bacteria with Triple Immune Nanoactivators Generates Tumor‐Resident Living Immunotherapeutics

Li, J., Xia, Q. H., Guo, H., Fu, Z., Liu, Y., Lin, S., & Liu, J. (2022) · Angewandte Chemie International Edition · doi:10.1002/anie.202202409 · Cited by 112 · see citing works

Advanced 3D imaging and organoid bioprinting for biomedical research and therapeutic applications

Maharjan, S., Ma, C., Singh, B., Kang, H., Orive, G., Yao, J., & Zhang, Y. S. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115237 · Cited by 105 · see citing works

Patient-derived organoids in human cancer: a platform for fundamental research and precision medicine

Qu, S., Xu, R., Yi, G., Li, Z., Zhang, H., Qi, S., & Huang, G. (2024) · Molecular Biomedicine · doi:10.1186/s43556-023-00165-9 · Cited by 97 · see citing works

Newly developed 3D in vitro models to study tumor–immune interaction

Mu, P., Zhou, S., Lv, T., Xia, F., Shen, L., Wan, J., Wang, Y., Zhang, H., Cai, S., Peng, J., et al. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02653-w · Cited by 82 · see citing works

In-situ cryo-immune engineering of tumor microenvironment with cold-responsive nanotechnology for cancer immunotherapy

Ou, W., Stewart, S., White, A. M., Kwizera, E. A., Xu, J., Fang, Y., Shamul, J. G., Xie, C., Nurudeen, S. M., Tirada, N. P., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36045-7 · Cited by 77 · see citing works

Harnessing 3D in vitro systems to model immune responses to solid tumours: a step towards improving and creating personalized immunotherapies

Zhou, Z., Pang, Y., Ji, J., He, J., Liu, T., Ouyang, L., Zhang, W., Zhang, X., Zhang, Z., Zhang, K., et al. (2023) · Nature reviews. Immunology · doi:10.1038/s41577-023-00896-4 · Cited by 73 · see citing works

A T Cell‐Engaging Tumor Organoid Platform for Pancreatic Cancer Immunotherapy

Zhou, Z., der Jeught, K. V., Li, Y., Sharma, S., Yu, T., Moulana, I., Liu, S., Wan, J., Territo, P. R., Opyrchal, M., et al. (2023) · Advanced Science · doi:10.1002/advs.202300548 · Cited by 65 · see citing works

Development of pharmacological immunoregulatory anti-cancer therapeutics: current mechanistic studies and clinical opportunities

Yin, N., Li, X., Zhang, X., Xue, S., Cao, Y., Niedermann, G., Lu, Y., & Xue, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01826-z · Cited by 66 · see citing works

A human mucosal melanoma organoid platform for modeling tumor heterogeneity and exploring immunotherapy combination options

Sun, L., Kang, X., Ju, H., Wang, C., Yang, G., Wang, R., & Sun, S. (2023) · Science Advances · doi:10.1126/sciadv.adg6686 · Cited by 58 · see citing works

Evaluation of cancer immunotherapy using mini-tumor chips

Ao, Z., Cai, H., Wu, Z., Hu, L., Li, X., Kaurich, C., Gu, M., Liang Cheng, C., Lü, X., & Guo, F. (2022) · Theranostics · doi:10.7150/thno.71761 · Cited by 52 · see citing works

Organoid Imaging: Seeing Development and Function

Keshara, R., Kim, Y. H., & Grapin‐Botton, A. (2022) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-120320-035146 · Cited by 50 · see citing works

Mechanisms of low MHC I expression and strategies for targeting MHC I with small molecules in cancer immunotherapy

Kong, S., Zhang, J., Wang, L., Li, W., Guo, H., Weng, Q., He, Q., Lou, H., Ding, L., & Yang, B. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.217432 · Cited by 50 · see citing works

Relapse after CAR-T cell therapy in B-cell malignancies: challenges and future approaches

Gu, T., Zhu, M., Huang, H., & Hu, Y. (2022) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2200256 · Cited by 44 · see citing works

Activation of the cGAS-STING pathway by a mitochondrial DNA-targeted emissive rhodium( iii ) metallointercalator

Zheng, Y., Chen, X., Zhang, D., Wang, W., Peng, K., Li, Z., Mao, Z., & Tan, C. (2023) · Chemical Science · doi:10.1039/d3sc01737k · Cited by 42 · see citing works

Epigenetic modulation of antitumor immunity and immunotherapy response in breast cancer: biological mechanisms and clinical implications

Yin, J., Gu, T., Chaudhry, N. Y., Davidson, N. E., & Huang, Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1325615 · Cited by 40 · see citing works

Galectin-7 Induction by EHMT2 Inhibition Enhances Immunity in Microsatellite Stability Colorectal Cancer

Sun, L., Liu, R., Wu, Z.-J., Liu, Z., Wan, A. H., Yan, S., Liu, C., Liang, H., Xiao, M., You, N., et al. (2023) · Gastroenterology · doi:10.1053/j.gastro.2023.11.294 · Cited by 41 · see citing works

Colorectal Cancer Immunotherapy: State of the Art and Future Directions

Cornista, A. M., Giolito, M. V., Baker, K., Hazime, H., Dufait, I., Datta, J., Khumukcham, S. S., De Ridder, M., Roper, J., Abreu, M. T., et al. (2023) · Gastro Hep Advances · doi:10.1016/j.gastha.2023.09.007 · Cited by 39 · see citing works

Organoid‐Guided Precision Medicine: From Bench to Bedside

Tao, B., Li, X., Hao, M., Tian, T., Li, Y., Li, X., Yang, C., Li, Q., Feng, Q., Zhou, H., et al. (2025) · MedComm · doi:10.1002/mco2.70195 · Cited by 38 · see citing works

Integration of organoids in peptide drug discovery: Rise of the high‐throughput screening

Zhang, S., Shen, J., Wang, X., Sun, X., Wu, Y., Zhang, M., Wang, R., & Hu, K. (2023) · Open Research (University of Surrey) · doi:10.1002/viw.20230010 · Cited by 33 · see citing works

On-chip modeling of tumor evolution: Advances, challenges and opportunities

Li, C., Holman, J. B., Shi, Z., Qiu, B., & Ding, W. (2023) · Materials Today Bio · doi:10.1016/j.mtbio.2023.100724 · Cited by 32 · see citing works

A state-of-the-art review on LSD1 and its inhibitors in breast cancer: Molecular mechanisms and therapeutic significance

Yang, G., Liu, Y., Ding, L., Tao, F., Zhu, M., Shi, Z.-Y., Wen, J.-M., Niu, M.-Y., Xiang, L., Xu, Z.-S., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.989575 · Cited by 27 · see citing works

Tumor organoids in immunotherapy: from disease modeling to translational research

Si, Q., Tao, S., Wu, J., Ma, J., Li, Z. Y., Feng, X., Song, J., Kong, T., & Zhou, Z. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2025-011733 · Cited by 30 · see citing works

Epigenetic deregulation in breast cancer microenvironment: Implications for tumor progression and therapeutic strategies

Trnkova, L., Buociková, V., Mego, M., Čumová, A., Buríková, M., Boháč, M., Miklikova, S., Cihova, M., & Smolková, B. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116559 · Cited by 28 · see citing works

Organoids: new frontiers in tumor immune microenvironment research

Yang, Y., Cui, J., Kong, Y., Hou, Y., & Ma, C. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1422031 · Cited by 24 · see citing works

The role of histone methylase and demethylase in antitumor immunity: A new direction for immunotherapy

Zhang, Y., Chen, J., Liu, H., Mi, R., Huang, R., Li, X., Fei, F., Xie, X., & Ding, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1099892 · Cited by 24 · see citing works

A multidimensional platform of patient-derived tumors identifies drug susceptibilities for clinical lenvatinib resistance

Sun, L., Wan, A. H., Yan, S., Liu, R., Li, J., Zhou, Z., Wu, R., Chen, D., Bu, X., Ou, J., et al. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.09.015 · Cited by 24 · see citing works

Epigenetic oncogenesis, biomarkers and emerging chemotherapeutics for breast cancer

Ayipo, Y. O., Ajiboye, A. T., Osunniran, W. A., Jimoh, A. A., & Mordi, M. N. (2022) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2022.194873 · Cited by 23 · see citing works

Exploring New Dimensions of Tumor Heterogeneity: The Application of Single Cell Analysis to Organoid‐Based 3D In Vitro Models

Landon‐Brace, N., Li, N. T., & McGuigan, A. P. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202300903 · Cited by 24 · see citing works

Organoids technology for advancing the clinical translation of cancer nanomedicine

Zhao, D., Liang, J., Huang, X., Shen, S., & Wang, J. (2023) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1892 · Cited by 22 · see citing works

Biomarkers and experimental models for cancer immunology investigation

Xu, H., Jia, Z., Liu, F., Li, J., Huang, Y., Jiang, Y., Pu, P., Shang, T., Tang, P., Zhou, Y., et al. (2023) · MedComm · doi:10.1002/mco2.437 · Cited by 20 · see citing works

Breast cancer organoids and their applications for precision cancer immunotherapy

Guan, D., Liu, X., Shi, Q., He, B., Zheng, C., & Meng, X. (2023) · World Journal of Surgical Oncology · doi:10.1186/s12957-023-03231-2 · Cited by 20 · see citing works

Stress Relaxation‐Induced Colon Tumor Multicellular Spheroid Culture Based on Biomimetic Hydrogel for Nanoenzyme Ferroptosis Sensitization Evaluation

Zhang, Y., Peng, L., Hu, K., & Gu, N. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202202009 · Cited by 20 · see citing works

LSD1: an emerging face in altering the tumor microenvironment and enhancing immune checkpoint therapy

Mamun, M., Zhang, Y., Jin-yuan, Z., Shen, D., Guo, T., Zheng, Y., Zhao, L., & Liu, H. (2023) · Journal of Biomedical Science · doi:10.1186/s12929-023-00952-0 · Cited by 20 · see citing works

Engineering Heterogeneous Tumor Models for Biomedical Applications

Wu, Z., Huang, D., Wang, J., Zhao, Y., Sun, W., & Shen, X. (2023) · Advanced Science · doi:10.1002/advs.202304160 · Cited by 19 · see citing works

Immune organoid for cancer immunotherapy

Wang, X., Wang, W., & Sun, Z. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.04.031 · Cited by 21 · see citing works

Epigenetic control of immunoevasion in cancer stem cells

Galassi, C., Esteller, M., Vitale, I., & Galluzzi, L. (2024) · Trends in cancer · doi:10.1016/j.trecan.2024.08.004 · Cited by 19 · see citing works

Acoustofluidic assembly of primary tumor-derived organotypic cell clusters for rapid evaluation of cancer immunotherapy

Wu, Z., Ao, Z., Cai, H., Li, X., Chen, B., Tu, H., Wang, Y., Lu, R. O., Gu, M., Liang Cheng, C., et al. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01786-6 · Cited by 18 · see citing works

Inhibition of Glutamate‐to‐Glutathione Flux Promotes Tumor Antigen Presentation in Colorectal Cancer Cells

Yu, T., der Jeught, K. V., Zhu, H., Zhou, Z., Sharma, S., Liu, S., Eyvani, H., So, K. M., Singh, N., Wang, J., et al. (2024) · Advanced Science · doi:10.1002/advs.202310308 · Cited by 18 · see citing works

TCR mimic compounds for pHLA targeting with high potency modalities in oncology

Gerber, H., & Presta, L. G. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1027548 · Cited by 18 · see citing works

Respiratory complex I regulates dendritic cell maturation in explant model of human tumor immune microenvironment

Turpin, R., Liu, R., Munne, P., Peura, A., Rannikko, J. H., Philips, G., Boeckx, B., Salmelin, N., Hurskainen, E., Suleymanova, I., et al. (2024) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2023-008053 · Cited by 17 · see citing works

Beyond Anti-PD-1/PD-L1: Improving Immune Checkpoint Inhibitor Responses in Triple-Negative Breast Cancer

Bullock, K. K., & Richmond, A. (2024) · Cancers · doi:10.3390/cancers16122189 · Cited by 17 · see citing works

Establishment of advanced tumor organoids with emerging innovative technologies

Mao, Y., & Hu, H. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.217122 · Cited by 16 · see citing works

Reprogramming the tumor microenvironment – macrophages emerge as key players in breast cancer immunotherapy

Sami, A., & Raza, A. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1457491 · Cited by 16 · see citing works

A knowledge-driven deep learning framework for organoid morphological segmentation and characterization

Qin, Y., Li, J., Heng, Y., Wang, Z., Wu, D., Rahman, M., Hu, P., Plötz, T., Hopp, A. V., Kurniawan, N. A., et al. (2025) · BMC Biology · doi:10.1186/s12915-025-02411-8 · Cited by 16 · see citing works

Quantitatively Evaluating Interactions between Patient-Derived Organoids and Autologous Immune Cells by Microfluidic Chip

Gao, M., Ding, W., Wang, Y., Li, B., Huang, Z., Liang, N., & Wei, Z. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.4c01389 · Cited by 14 · see citing works

Integration of Tumor Microenvironment in Patient-Derived Organoid Models Help Define Precision Medicine of Renal Cell Carcinoma

Wang, B., Xue, Y., & Zhai, W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.902060 · Cited by 15 · see citing works

Organoids as an Enabler of Precision Immuno-Oncology

Zhao, J., Fong, A. S. W., Seow, S. V., & Toh, H. C. (2023) · Cells · doi:10.3390/cells12081165 · Cited by 13 · see citing works

Tumor organoids in cancer medicine: from model systems to natural compound screening

Cong, R., Lu, C., Li, X., Xu, Z., Wang, Y., & Sun, S. (2025) · Pharmaceutical Biology · doi:10.1080/13880209.2025.2458149 · Cited by 14 · see citing works

Human Liver Organoid Models for Assessment of Drug Toxicity at the Preclinical Stage

Karabicici, M., Akbari, S., Ertem, Ö., Gümüştekin, M., & Erdal, E. (2023) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530323666230411100121 · Cited by 12 · see citing works

Engineering blood–brain barrier microphysiological systems to model Alzheimer's disease monocyte penetration and infiltration

Gu, L., Mao, X., Tian, C., Yang, Y., Yang, K., Canfield, S. G., Zhu, D., Gu, M., & Guo, F. (2025) · Biomaterials Science · doi:10.1039/d5bm00204d · Cited by 12 · see citing works

Exploring tumor organoids for cancer treatment

Jin, H., Yang, Q., Yang, J., Wang, F., Feng, J., Lei, L., & Dai, M. (2024) · APL Materials · doi:10.1063/5.0216185 · Cited by 11 · see citing works

In situ growth of electroactive polymers via ATRP to construct a biosensing interface for tumor marker

Wang, F., Xu, Y. J., Han, H., & Ma, Z. (2021) · Microchimica Acta · doi:10.1007/s00604-021-05048-w · Cited by 11 · see citing works

Fuzzy Mixture-of-Experts Aggregation for Organoid Identification With Multiscale State Space Features

Deng, X., Hu, P., Herget, T., Tan, F., Zhu, X., Zhang, J., Huang, Y., Hu, L., You, Z., & Luo, X. (2025) · IEEE Transactions on Fuzzy Systems · doi:10.1109/tfuzz.2025.3622935 · Cited by 10 · see citing works

Applications and evolution of 3D cancer-immune cell models

Co, I. L., Fomina, A., Nurse, M., & McGuigan, A. P. (2024) · Trends in biotechnology · doi:10.1016/j.tibtech.2024.06.008 · Cited by 10 · see citing works

Application and prospect of organoid technology in breast cancer

Huang, S., Mei, Z., Wan, A., Zhao, M., & Qi, X. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1413858 · Cited by 11 · see citing works

A Comprehensive Review of Natural Products as Therapeutic or Chemopreventive Agents against Head and Neck Squamous Cell Carcinoma Cells Using Preclinical Models

Liew, Y. X., Karen‐Ng, L. P., & Vincent–Chong, V. K. (2023) · Biomedicines · doi:10.3390/biomedicines11092359 · Cited by 10 · see citing works

Ex Vivo Evaluation of Combination Immunotherapy Using Tumor‐Microenvironment‐on‐Chip

Mu, H., Lin, C., Chu, L., Lin, Y., Li, J., Liu, C., Huang, H., Cheng, S., Lee, T., Lee, H. M., et al. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202302268 · Cited by 9 · see citing works

Regulation of T cells in the tumor microenvironment by histone methylation: LSD1 inhibition—a new direction for enhancing immunotherapy

Xueqing, X., Yongcan, P., Wei, L., Qingling, Y., & Jie, D. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e24457 · Cited by 9 · see citing works

Tumor‐Targeting Co‐Delivery of T‐Cell Antigen and Camptothecin Guided by Cascade‐Responsive Peptide Self‐Assembly to Reshape Tumor Antigenicity for Cancer Immunotherapy

Ding, Y., Zhu, X., Wen, J., Xiong, J., Zhang, S., Yang, Z., & Hu, Z. (2025) · Advanced Materials · doi:10.1002/adma.202516767 · Cited by 8 · see citing works

Colorectal cancer organoids drive hypoxia, TGF-β, and patient-specific diversification of NK cell activation programs

von Kries, A., Garcés-Lázaro, I., Balzasch, B. M., Sticht, C., Shaltiël, I. A., Boonekamp, K. E., Sams, A., Triassi, A., Hofman, T., Burgermeister, E., et al. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2025-012988 · Cited by 8 · see citing works

CUDC-101 as a dual-target inhibitor of EGFR and HDAC enhances the anti-myeloma effects of bortezomib by regulating G2/M cell cycle arrest

Cao, G., Yao, S., Li, A., Chen, H., Zhang, E., Cao, L., Zhang, J., Hou, Y., Dai, Z., Chen, J., et al. (2023) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2200465 · Cited by 8 · see citing works

Enzyme-Instructed Photoactivatable Supramolecular Antigens on Cancer Cell Membranes for Precision-Controlled T-Cell-Based Cancer Immunotherapy

Ding, Y., Zhang, S., Li, W., Chen, X., Li, J., Zhang, X., Zhang, Z., Hu, Y., Yang, Z., Hu, Z., et al. (2024) · Nano Letters · doi:10.1021/acs.nanolett.4c01587 · Cited by 7 · see citing works

Decorating Bacteria with Triple Immune Nanoactivators Generates Tumor‐Resident Living Immunotherapeutics

Li, J., Xia, Q. H., Guo, H., Fu, Z., Liu, Y., Lin, S., & Liu, J. (2022) · Angewandte Chemie · doi:10.1002/ange.202202409 · Cited by 7 · see citing works

Reprogramming intratumoral T reg cells by morpholino-mediated splicing of FOXP3 for cancer immunotherapy

Li, Y., Singh, N., Dong, C., Sharma, S., Zhou, Z., Du, J., Haouili, M., Jiao, Y., Hopewell, E. L., Liu, Y., et al. (2025) · Science Immunology · doi:10.1126/sciimmunol.adr9933 · Cited by 6 · see citing works

Organoids in cancer therapy: translational applications and clinical promise

Bai, M., Liu, M., Wang, S., Ran, M., Ye, J., 薛玉芹, Zhang, C., Wang, Y., Lu, J., Dai, F., et al. (2026) · Molecular Cancer · doi:10.1186/s12943-026-02678-7 · Cited by 6 · see citing works

Current applications of tumor local ablation (TLA) combined with immune checkpoint inhibitors in breast cancer treatment

Tang, L., Wang, D., Hu, T., Lin, X., & Wu, S. (2024) · Cancer Drug Resistance · doi:10.20517/cdr.2024.77 · Cited by 6 · see citing works

Interfacial T cell engineering

Alapan, Y., & Thomas, S. N. (2025) · Nature Reviews Bioengineering · doi:10.1038/s44222-025-00316-3 · Cited by 6 · see citing works

CAMPEOD: A Cross Attention-Based Multi-Scale Patch Embedding Organoid Detection Model

Deng, X., Hu, L., You, Z., & Hu, P. (2023) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm58861.2023.10385689 · Cited by 6 · see citing works

3D cell culture models: how to obtain and characterize the main models

Abdurakhmanova, M., Leonteva, A. A., Vasilieva, N. S., Kuligina, E. V., & Nushtaeva, A. A. (2025) · Vavilov Journal of Genetics and Breeding · doi:10.18699/vjgb-25-21 · Cited by 5 · see citing works

Combination of tumor organoids with advanced technologies: A powerful platform for tumor evolution and treatment response (Review)

Wu, Y. H., Zhang, F., Du, F., Huang, J., & Wei, S. (2025) · Molecular Medicine Reports · doi:10.3892/mmr.2025.13505 · Cited by 7 · see citing works

IR783‐Stabilized Nanodrugs Enhance Anticancer Immune Response by Synergizing Oxidation Therapy and Epigenetic Modulation

Liu, J., Wu, M., Lyu, Q., Yang, C., Fan, N., Chen, K., & Wang, W. (2025) · Advanced Science · doi:10.1002/advs.202415684 · Cited by 5 · see citing works

MSSOrg: a multi-scale SSM-based model for organoid location and classification

Deng, X., Li, Z., Mei, G., Liang, S., Sun, T., Shang, Z., Yang, Y., Wei, Y., Hu, L., & Hu, P. (2024) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm62325.2024.10822007 · Cited by 5 · see citing works

Identification of the Immune Subtype of Hepatocellular Carcinoma for the Prediction of Disease-Free Survival Time and Prevention of Recurrence by Integrated Analysis of Bulk- and Single-Cell RNA Sequencing Data

Fu, J., & Lei, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.868325 · Cited by 6 · see citing works

Evolution and hotspots in breast cancer organoid research: insights from a bibliometric and visual knowledge mapping study (2005-2024)

Wu, T., Li, B., Hao, L., Zhao, F., & Liu, Z. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1604362 · Cited by 5 · see citing works

Methylstat sensitizes ovarian cancer cells to PARP-inhibition by targeting the histone demethylases JMJD1B/C

Schwarz, F. M., Klotz, D. M., Yang, R., Brux, M., Buchholz, F., Harb, H., Link, T., Wimberger, P., Theis, M., & Kuhlmann, J. D. (2025) · Cancer Gene Therapy · doi:10.1038/s41417-025-00874-z · Cited by 4 · see citing works

Tumor organoid-immune cell co-culture systems for precision oncology

Cai, L., Xiao, Y., Xie, F., & Yang, Z.-Y. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1865487 · Cited by 3 · see citing works

Injectable and conductive cardiac patch

Lim, G. B. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00639-9 · Cited by 3 · see citing works

From 3D culture to clinical decision-making: Systematic innovations in breast cancer organoids

Hu, M., Zhou, C., Li, M., & Zhao, J. (2025) · Biomaterials Advances · doi:10.1016/j.bioadv.2025.214528 · Cited by 2 · see citing works

Identifying phenotype-genotype-function coupling in 3D organoid imaging using Shape, Appearance and Motion Phenotype Observation Tool (SPOT)

Zhou, F., Jacobs, B., Norton-Steele, A., Han, X., Zhou, L., Carroll, T. M., Puig, C. R., Chadwick, J., Qin, X., Lisle, R., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-75506-7 · Cited by 2 · see citing works

The Trojan Horse Within: Mechanisms of Immune Evasion in Breast Cancer

Das, B., Winterbottom, C. W., & Sikandar, S. S. (2025) · Cancer Heterogeneity and Plasticity · doi:10.47248/chp2603010001 · Cited by 2 · see citing works

Patient-derived tumor organoids for new drug development: promises and challenges

He, M., Wu, Y., Du, F., Wang, J., Zhang, H., & Han, J. (2026) · Investigational New Drugs · doi:10.1007/s10637-026-01605-3 · Cited by 3 · see citing works

Respiratory Complex I Regulates Dendritic Cell Maturation in Explant Model of Human Tumor Immune MicroenvironmentPreprint

Turpin, R., Liu, R., Munne, P., Peura, A., Rannikko, J. H., Philips, G., Boeckx, B., Salmelin, N., Hurskainen, E., Suleymanova, I., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.10.539944 · Cited by 2 · see citing works

Methods and applications of patient-derived organoid models for immune microenvironment and immunotherapy research in multiple cancer types

Yu, Y., Li, Y., Wang, J., Zhu, Y.-J., Zhang, Z., Xiao, Z., Chen, Y., Qu, Y., Han, L., & Zhang, H. (2026) · Experimental Hematology and Oncology · doi:10.1186/s40164-026-00757-5 · Cited by 2 · see citing works

Contribution of intestinal mucosa to the disease mechanisms of Spondyloarthritis: Unlocking new insights through bioengineered tissue models

Natalello, G., Lorenzis, E. D., D’Agostino, M. A., Langella, P., Bréban, M., Cherbuy, C., & Bazin, T. (2026) · Autoimmunity Reviews · doi:10.1016/j.autrev.2026.104038 · Cited by 1 · see citing works

Tumor Organoid and Microenvironment Cocultures: Implications for Basic and Translational Cancer Research

Yang, J., Cheng, C., Luo, W., He, X., Li, Y., Hu, X., Cai, S., Zou, H., Mo, S., & Peng, J. (2026) · MedComm · doi:10.1002/mco2.70741 · Cited by 2 · see citing works

Cancer Cell-Intrinsic Programs That Shape Tumor Immune Ecosystems

Wang, L., Guo, Y., Ma, L., & Miao, K. (2026) · Cancer Biome and Targeted Therapy · doi:10.66505/cbtt.v1i2.33 · Cited by 1 · see citing works

GSH/pH-Sensitive Poly(glycerol sebacate dithiodiglycolate) Nanoparticle as a Ferroptotic Inducer through Cooperation with Fe3+

Jiang, Y.-S., Huang, C.-R., Chen, C., & Jan, J. (2024) · ACS Applied Polymer Materials · doi:10.1021/acsapm.3c01770 · Cited by 1 · see citing works

Frozen silicified vaccines

Dart, A. (2021) · Nature reviews. Cancer · doi:10.1038/s41568-021-00428-z

CHA1: A New Combinatorial Therapy That Reciprocally Regulates Wnt and JAK/STAT/Interferon Signaling to Re-program Breast Tumors and the Tumor-Resident LandscapePreprint

Alamoudi, M. K., Chipman, M. E., Deieso-Frechette, F., Bogis, A. M., Alqurashi, R. S., Li, K., Zhang, R., Castañer, M., Triafallou, G., Herbosa, C. G., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.03.25.485706

Diagnosing Immune Checkpoint Inhibitor-Induced Myocarditis: Insights, Challenges, and Uncertainties

Lu, L., Wang, X., & Xu, H. (2024) · Cardiovascular Innovations and Applications · doi:10.15212/cvia.2024.0039

Cytotoxicity and inhibitory potential of CUDC-101 in non-small cell lung cancer cells with rare EGFR L861Q mutation

Chu, C., Xu, H., Liu, C., Wei, X., Li, L., Wang, R., Cui, W., Zhang, G., Liu, C., Wang, K., et al. (2024) · Current Research in Toxicology · doi:10.1016/j.crtox.2024.100194

A Knowledge-driven Deep Learning Framework for Organoid Morphological Segmentation and CharacterisationPreprint

Qin, Y., Li, J., Yin, H., Wu, D., Liu, X., Plötz, T., Hopp, A. V., Kurniawan, N. A., Winkel, M., Harbach, P. H. P., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-5380950/v1

Advances in basic and translational research on the heterogeneity and metastatic mechanisms of primary liver cancer

Wang, Y., Chen, L., & Zhang, N. (2025) · Visualized Cancer Medicine · doi:10.1051/vcm/2025012

Additional file 1 of Acoustofluidic assembly of primary tumor-derived organotypic cell clusters for rapid evaluation of cancer immunotherapy

Wu, Z., Ao, Z., Cai, H., Li, X., Chen, B., Tu, H., Wang, Y., Lu, R. O., Gu, M., Cheng, L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26566340

Three-dimensional bioprinting techniques for cancer: organoid models and applications

Indrakumar, J., Kesavan, A., & Nirmala, M. J. (2025) · Organoid · doi:10.51335/organoid.2025.5.e11

Epigenetic reprogramming of myeloid-derived suppressor cells sensitizes breast and pancreatic cancers to immune checkpoint inhibition

Christmas, B. J. (2019)

Integrative single-cell and pan-cancer analyses identify LINC01871 and TBX21 as candidate regulators of antitumor T-cell immunity in breast cancerPreprint

Chen, X., Tang, T., Da, W., Chen, T., Wang, H., & Yu, P. (2026) · Research Square · doi:10.21203/rs.3.rs-10586247/v1

An epigenetic modifier triggers therapeutic immune responses against breast cancer

Galluzzi, L., & Kroemer, G. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1313376 · Cited by 4 · see citing works

Epigenetic modulation of antitumor immunity and immunotherapy response in breast cancer: biological mechanisms and clinical implications

Yin, J., Gu, T., Chaudhry, N. Y., Davidson, N. E., & Huang, Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1325615 · Cited by 40 · see citing works

Developing a screening platform for genetic and small molecule targets of cancer immunotherapy.

Upadhyay, R., Wroblewska, A., Koo, C., Brown, B. D., & Brody, J. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2018.36.5_suppl.66